{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:20:50Z","timestamp":1758626450002,"version":"3.44.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"name":"UK MRC Centre for Global Infectious Disease Analysis","award":["MR\/X020258\/1"],"award-info":[{"award-number":["MR\/X020258\/1"]}]},{"DOI":"10.13039\/100018336","name":"NIHR Health Protection Research Unit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009660","name":"London School of Hygiene & Tropical Medicine","doi-asserted-by":"publisher","award":["NIHR200908"],"award-info":[{"award-number":["NIHR200908"]}],"id":[{"id":"10.13039\/100009660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,15]]},"DOI":"10.1093\/infdis\/jiaf200","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T14:30:12Z","timestamp":1744727412000},"page":"e550-e551","source":"Crossref","is-referenced-by-count":0,"title":["Further Evidence and Analysis are Required to Determine the Level of Protection Against Gonorrhea Provided by 4CMenB"],"prefix":"10.1093","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0391-9015","authenticated-orcid":false,"given":"Dariya","family":"Nikitin","sequence":"first","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis and NIHR Health Protection Research Unit in Modelling and Health Economics, Imperial College London , London ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6644-3512","authenticated-orcid":false,"given":"Peter J","family":"White","sequence":"additional","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis and NIHR Health Protection Research Unit in Modelling and Health Economics, Imperial College London , London ,","place":["United Kingdom"]},{"name":"Modelling and Economics Unit, UK Health Security Agency , London ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"journal-title":"J Infect Dis","article-title":"The available evidence does not support the claim of Nitikin et al that 4CMenB is a cost-effective way to reduce gonorrhea incidence","author":"Kenyon","key":"2025092306174958600_jiaf200-B1"},{"key":"2025092306174958600_jiaf200-B2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1473-3099(21)00812-4","article-title":"Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study","volume":"22","author":"Abara","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025092306174958600_jiaf200-B3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/infdis\/jiae123","article-title":"Cost-effectiveness of 4CMenB vaccination against gonorrhea: importance of dosing schedule, vaccine sentiment, targeting strategy, and duration of protection","volume":"231","author":"Nikitin","year":"2025","journal-title":"J Infect Dis"},{"key":"2025092306174958600_jiaf200-B4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","article-title":"Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 \u00d7 2 factorial design","volume":"24","author":"Molina","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025092306174958600_jiaf200-B5","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.1016\/S1473-3099(24)00031-8","article-title":"Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK","volume":"24","author":"Ladhani","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025092306174958600_jiaf200-B6","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/OLQ.0000000000001793","article-title":"Healthy vaccinee bias and MenB-FHbp vaccine effectiveness against gonorrhea","volume":"50","author":"Abara","year":"2023","journal-title":"Sex Transm Dis"},{"key":"2025092306174958600_jiaf200-B7","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S1473-3099(21)00744-1","article-title":"Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis","volume":"22","author":"Whittles","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025092306174958600_jiaf200-B8","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S1473-3099(24)00452-3","article-title":"The potential role of the 4CMenB vaccine in combating gonorrhoea: the need for nuance in interpreting the DOXYVAC trial","volume":"24","author":"White","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025092306174958600_jiaf200-B9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1473-3099(18)30341-4","article-title":"Testing for gonorrhoea should routinely include the pharynx","volume":"18","author":"Whittles","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025092306174958600_jiaf200-B10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1473-3099(22)00343-7","article-title":"We need estimates of gonorrhoea vaccine protection and symptomaticity by sex and anatomical site","volume":"22","author":"White","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025092306174958600_jiaf200-B11","doi-asserted-by":"crossref","first-page":"ofae562","DOI":"10.1093\/ofid\/ofae562","article-title":"Breakthrough rectal Neisseria gonorrhoeae infections after meningococcal B vaccination: microbiological and clinical features","volume":"11","author":"Raccagni","year":"2024","journal-title":"Open Forum Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf200\/62933707\/jiaf200.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/3\/e550\/62933707\/jiaf200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/3\/e550\/62933707\/jiaf200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T10:24:46Z","timestamp":1758623086000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/232\/3\/e550\/8113947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,4,15]]},"published-print":{"date-parts":[[2025,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf200","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"type":"print","value":"0022-1899"},{"type":"electronic","value":"1537-6613"}],"subject":[],"published-other":{"date-parts":[[2025,9,15]]},"published":{"date-parts":[[2025,4,15]]}}}